Corton Capital’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-946
| Closed | -$223K | – | 176 |
|
|
2024
Q4 | $223K | Buy |
+946
| New | +$223K | 0.13% | 225 |
|
|
2024
Q2 | – | Sell |
-3,004
| Closed | -$449K | – | 490 |
|
|
2024
Q1 | $449K | Sell |
3,004
-1,823
| -38% | -$272K | 0.17% | 157 |
|
|
2023
Q4 | $924K | Buy |
4,827
+3,489
| +261% | +$668K | 0.29% | 56 |
|
|
2023
Q3 | $237K | Sell |
1,338
-1,553
| -54% | -$275K | 0.12% | 258 |
|
|
2023
Q2 | $549K | Buy |
+2,891
| New | +$549K | 0.26% | 87 |
|